Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation.
Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation.
复制标题
视网膜母细胞瘤患者摘除后多孔聚乙烯植入物暴露的处理。
DOI:
10.3928/1542-8877-20041101-03
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
Y. Yu
中科院分区:
文献类型:
--
作者:
Jonghyun Kim;S. Khwarg;H. Choung;Y. Yu
BACKGROUND AND OBJECTIVE
To report the features and the management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation.
PATIENTS AND METHODS
The medical records of 33 patients (33 sockets) following enucleation and porous polyethylene implantation for retinoblastoma were reviewed.
RESULTS
The mean age at enucleation was 24 months (range, 2 to 85 months). The exposure rate was 33% (11 cases), and the mean time from enucleation to exposure was 15 months (range, 7 to 29 months). One case was resolved only by supportive management, and the remaining 10 were successfully treated with a scleral patch graft and maintained well during a mean follow-up of 15 months after surgical repair. There was no statistical evidence that age, gender, implant size, or chemotherapy had an effect on implant exposure.
CONCLUSIONS
Porous polyethylene implant exposure does not seem to be resolved by conservative management. We recommend early surgical management, such as scleral patch graft, as opposed to supportive management.